News Mallinckrodt pays US authorities $100m in pricing case Price of epilepsy drug increased 85,000% since 2001, says FTC.
News Takeda to challenge GW Pharma with epilepsy deal Takeda makes epilepsy deal as GW prepares for US filing.
News Kite aims for Asia market with CAR-T deals in China, Japan California's Kite strikes deals with Fosun and Daiichi Sankyo.
News Outlook bright for Vertex despite European delays But analysts excited by promise of next generation of medicines.
News Amicus set for share of Fabry market after NICE approval England and Wales’ cost effectiveness watchdog NICE has given a final recommendation to a new treatment for the rare Fabry disease.
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
